Gsm Foils Ltd · NSE:GSMFOILS
Gsm Foils — Q1 FY27 Earnings Presentation
32 slides from Gsm Foils's earnings presentation, Jul 21, 2026
Slide 1: Regulation 30 Cover Letter to NSE
GSM FOILS LIMITED CIN: L43303MH2023PLC405459 REGISTERED OFFICE: GALA NO 06/106/206/306, SAPPHIRE BUILDING, DIAMOND INDUSTRIAL ESTATE, VASAI (E), PALGHAR - 401208, MAHARASHTRA PHONE NO.: +91 91 84689 68102 EMAIL ID: info@gsmfoils.com WEBSITE: www.gsmfoils.com July 20, 2026 To, National Stock Exchange
Slide 2: GSM Foils Ltd Investor Presentation July 2026
GSM Foils Ltd Investor Presentation July 2026
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by GSM Foils Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities,
Slide 4: Table of Contents
TABLE OF CONTENTS Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance 01 02 03 04 05
Slide 5: GSM Foils At A Glance
GSM Foils At A Glance • Established in 2019, GSM Foils specializes in the manufacturing of a wide range of Blister Foils and Aluminium Pharma Foils for the pharmaceutical industry. • We source raw materials from reputed, industry-recognized vendors, ensuring consistency and reliability in product qu
Slide 6: Company Snapshot
Company Snapshot ~31,500 Sq. 17,000+ 2019 14+ Ft MT/Annum Year of Establishment Presence in States Manufacturing Area Production Capacity ISO 20 – 40 96.9 Cr 7.6 Cr 9001:2015 Microns Q1 FY27 Revenue Q1 FY27 PAT Certification Product Range 21+ 110+ 82+ In-House Advance Units Client Base Employees QA
Slide 7: Our Journey
Our Journey Formed company Touched almost Achieved the Converted LLP firm to milestone of crossing in the name of 80 % of our public limited and 100 Cr+ Annual GSM FOILS LLP capacity during shifted to new Turnover. and started peak covid and did premises for further Operationalized a aluminum foil a
Slide 8: Product Portfolio
Product Portfolio Blister Foil Aluminium Strip Pharma Foils Aluminium ROPP Caps Blister Pack Formation Superior Protection Secure & Tamper-Evident Seal Consist of a thermoformed plastic tray or cold- Aluminium foils provide complete insulation against ROPP Caps provide a leak-proof, tamper-evident f
Slide 9: Blister Foils
Blister Foils Push-Through Blister Peel-Push Blister Packaging Packaging Medication is dispensed by peeling Medication is released by tearing open back the lidding and pushing through the package, constructed from paper, the aluminium foil; lidding is layered PET, and aluminium foil/HSC. with paper
Slide 10: Aluminium Strip Pharma Foils
Aluminium Strip Pharma Foils 30-micron Strip Foil 40-micron Strip Foil A thicker 40-micron aluminum foil A 30-micron aluminum foil with 150 with 150 GSM LDPE, providing GSM LDPE, designed for standard enhanced strength and barrier pharmaceutical packaging. properties. Used for packaging moisture-sen
Slide 11: Comprehensive Quality Control Measures
Comprehensive Quality Control Measures Bursting Strength Test GSM Calculator Measures the maximum pressure required to rupture the foil, ensuring Calculates the grammage per square meter, ensuring material consistency durability. and quality. Peeling Strength Test Digital Controlled Hot Plate Assess
Slide 12: Manufacturing Facility - Unit 1 - Vasai, Maharashtra
Manufacturing Facility - Unit 1 - Vasai, Maharashtra • Our 7,973 sq. ft. manufacturing facility in Vasai, Mumbai, spanning ground plus three floors, is strategically designed to support comprehensive, end-to-end operations. The facility seamlessly integrates R&D, production, quality testing, packagi
Slide 13: Manufacturing Facility - Unit 2 - Ahmedabad, Gujarat
Manufacturing Facility - Unit 2 - Ahmedabad, Gujarat Strategic Capacity Expansion to Support Growth 17,000 Sq Ft 10k+ MT 80%+ Approximate Annual Utilization target Leased Area Capacity by March 2027 • The Ahmedabad facility has been established to support the next phase of GSM Foils’ growth by expan
Slide 14: Manufacturing Facility - Unit 3 (ROPP Caps Unit) - Mumbai
Manufacturing Facility - Unit 3 (ROPP Caps Unit) - Mumbai, Maharashtra New ROPP Caps Unit to Drive Profitable Growth New Line of End Use: ~₹50 Crore Higher Margin Used in various syrup Business: & similar bottles and Potential Annual Profile: ROPP Caps made alcohol & beverage Revenue at Peak Compare
Slide 15: Delivering Value Through Quality, Customization, and Innovation
Delivering Value Through Quality, Customization, and Innovation Quality Assurance & Tailored Client Continuous Product Strategic Supplier Compliance Solutions Innovation Partnerships Ensures top-quality Offers customized Continuous Strong supplier products through packaging and investment in R&D par
Slide 16: Our Management Team
Our Management Team Mohansingh L Parmar Sagar Girish Bhanushali Managing Director CFO, Whole Time Director 15 • Completed Primary Education under the • Holds a Bachelor’s Degree in Commerce from the Maharashtra State Board and FYJC from P.D. Lions University of Mumbai (2015). College of Commerce & E
Slide 17: Certifications
Certifications ISO CERTIFICATE RESIDUAL -SOLVENT DECLARATION TSE/BSE DECLARATION FOOD GRADE DECLARATION BIS CERTIFICATE CGMP CERTIFICATE 16 Investor Presentation - Q1 FY27
Slide 18: Table of Contents
TABLE OF CONTENTS Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance 01 02 03 04 05
Slide 19: India & the World: Expanding Opportunities in Pharma-Focused Foil Packaging
India & the World: Expanding Opportunities in Pharma-Focused Foil Packaging India: A Growing Market for Aluminium Foils Global Aluminium Foil Market: Expanding Horizons • Global market size estimated at USD 32 billion in 2025 and is anticipated • India is among the fastest-growing packaging markets
Slide 20: Industry Tailwinds for Aluminium Foils in Pharma Applications
Industry Tailwinds for Aluminium Foils in Pharma Applications Rising Pharmaceutical Regulatory Push for Tamper- Innovation in Drug Growth in Generic Biosimilars & Exports from India Proof, Barrier Delivery – Rise in Drugs & OTC Market Biologics Boom Grade Packaging Blister Packaging • India supplies
Slide 21: Table of Contents
TABLE OF CONTENTS Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance 01 02 03 04 05
Slide 22: Our Strategic Growth Roadmap
Our Strategic Growth Roadmap Manufacturing Capacity Expansion: We are planning to establish a new manufacturing facility, targeted to be operational in the first half of FY27. This expansion will enhance production capacity, improve efficiency, and support long-term growth. Geographic Expansion: We
Slide 23: Our Core Strengths
Our Core Strengths 4 Operational Excellence 2 1 To remain cost-competitive and improve profitability, we continuously work on optimizing internal processes. Our 24-hour manufacturing operation ensures productivity across three shifts. We also focus on process 3 4 improvements, better inventory contr
Slide 24: Table of Contents
TABLE OF CONTENTS Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance 01 02 03 04 05
Slide 25: Quarterly Performance Highlights
Quarterly Performance Highlights Revenue (INR Lacs) EBITDA (INR Lacs) and EBITDA Margin (%) PAT (INR Lacs) and PAT Margin (%) +86.3% +97.7% +98.8% 1,151.2 761.8 9,688.6 5,200.0 582.3 383.2 11.9% 7.9% 11.2% 7.4% Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Investor Presentation - Q1 FY27
Slide 26: Quarterly Income statement
Quarterly Income statement Particulars (In INR Lacs) Q1 FY27 Q1 FY26 Y-o-Y Q4 FY26 Q-o-Q Revenue from Operations 9,688.6 5,200.0 86.3% 8,168.9 18.6% Cost of Materials consumed 7,659.8 4,700.0 7,594.6 Changes in Inventories of finished goods, work-in-progress 615.6 -226.2 -651.9 and stock-in-trade Gr
Slide 27: Table of Contents
TABLE OF CONTENTS Company Overview Industry Overview Strategic Overview Quarterly Financial Performance Historical Financial Performance 01 02 03 04 05
Slide 28: Historical Income statement
Historical Income statement Particulars (In INR Lacs) FY24* FY25 FY26 Q1 FY27 Revenue from Operations 4,083.4 13,380.0 25,815.4 9,688.6 Cost of Materials consumed 3,557.3 11,586.0 23,459.8 7,659.8 Changes in Inventories of finished goods, work-in-progress and stock-in-trade -250.4 -398.4 -1,539.8 61
Slide 29: Historical Balance Sheet
Historical Balance Sheet Equity & Liabilities(In INR Lacs) Mar-24 Mar-25 Mar-26 Assets(In INR Lacs) Mar-24 Mar-25 Mar-26 Shareholders' Fund Non ‐ Current Assets (a) Equity share capital 937.2 1,281.2 1,409.3 (a) Property, plant and equipment (b) Other equity 166.1 1,843.1 6,037.0 (i) Tangible Assets
Slide 30: Historical Cash Flow Statement
Historical Cash Flow Statement Particulars (In INR Lacs) Mar-24 Mar-25 Mar-26 Cash Flow from Operating Activities Profit before Tax 185.3 1,362.8 2,669.2 Adjustment for Non-Operating Items 13.3 28.2 9.3 Operating Profit before Working Capital Changes 198.5 1,391.0 2,678.4 Changes in Working Capital
Slide 31: Growth in Key Ratios
Growth in Key Ratios Revenue (INR Lacs) EBITDA (INR Lacs) and EBITDA Margin (%) PAT (INR Lacs) and PAT Margin (%) 25,815.4 2,978.3 1,983.7 13,380.0 1,520.5 9,688.6 965.1 1,151.2 761.8 11.4% 11.5% 11.9% 4,083.4 7.7% 7.9% 270.0 136.8 7.2% 6.6% 3.4% FY24 FY25 FY26 Q1 FY27 FY24 FY25 FY26 Q1 FY27 FY24 FY
Slide 32: Thank You!
GSM Foils Limited CIN: L43303MH2023PLC405459 Email ID: investors@gsmfoils.com Tel: +9184689 68102 Website: www.gsmfoils.com Thank You! Investor Relations Partner X-B4 Advisory LLP Rasika Sawant / Aagam Shah Tel: +91 95944 57518 / +91 8850166932 Email ID: rasika@x-b4.com / aagam@x-b4.com Website: www